JMD ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sandberg, Y.
Right arrow Articles by Langerak, A. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sandberg, Y.
Right arrow Articles by Langerak, A. W.
JMD 2005, Vol. 7, No. 4
Copyright © 2005 American Society for Investigative Pathology & Association for Molecular Pathology

BIOMED-2 Multiplex Immunoglobulin/T-Cell Receptor Polymerase Chain Reaction Protocols Can Reliably Replace Southern Blot Analysis in Routine Clonality Diagnostics

Yorick Sandberg*, Ellen J. van Gastel-Mol*, Brenda Verhaaf*, King H. Lam{dagger}, Jacques J.M. van Dongen* and Anton W. Langerak*

From the Departments of Immunology * and Pathology, {dagger} Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands

To establish the most sensitive and efficient strategy of clonality diagnostics via immunoglobulin and T-cell receptor gene rearrangement studies in suspected lymphoproliferative disorders, we evaluated 300 samples (from 218 patients) submitted consecutively for routine diagnostics. All samples were studied using the BIOMED-2 multiplex polymerase chain reaction (PCR) protocol. In 176 samples, Southern blot (SB) data were also available, and the two types of molecular results were compared. Results of PCR and SB analysis of both T-cell receptor and immunoglobulin loci were concordant in 85% of samples. For discordant results, PCR results were more consistent with the final diagnosis in 73% of samples. No false-negative results were obtained by PCR analysis. In contrast, SB analysis failed to detect clonality in a relatively high number of samples, mainly in cases of low tumor burden. We conclude that the novel BIOMED-2 multiplex PCR strategy is of great value in diagnosing patients with suspected B- and T-cell proliferations. Because of its higher speed, efficiency, and sensitivity, it can reliably replace SB analysis in clonality diagnostics in a routine laboratory setting. Just as with SB results, PCR results should always be interpreted in the context of clinical, immunophenotypical, and histopathological data.




This article has been cited by other articles:


Home page
J. Mol. Diagn.Home page
F. C. Kuo, D. Hall, and J. A. Longtine
A Novel Method for Interpretation of T-Cell Receptor {gamma} Gene Rearrangement Assay by Capillary Gel Electrophoresis Based on Normal Distribution
J. Mol. Diagn., February 1, 2007; 9(1): 12 - 19.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
B. T. Tan, R. A. Warnke, and D. A. Arber
The Frequency of B- and T-Cell Gene Rearrangements and Epstein-Barr Virus in T-Cell Lymphomas: A Comparison Between Angioimmunoblastic T-Cell Lymphoma and Peripheral T-Cell Lymphoma, Unspecified With and Without Associated B-Cell Proliferations
J. Mol. Diagn., September 1, 2006; 8(4): 466 - 475.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Society for Investigative Pathology and the Association for Molecular Pathology.